| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $139.6M | -18.7% | -13.6% |
| Cost of Revenue | $35.5M | -9.5% | -0.9% |
| Gross Profit | $104.1M | -21.5% | -17.2% |
| R&D Expense | $36.3M | -0.1% | +0.7% |
| SG&A Expense | $18.0M | -11.7% | +15.2% |
| Operating Income | $43.1M | -37.1% | -35.6% |
| Pre-tax Income | $54.1M |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $121.6M | +26.9% | +52.9% |
| Short-term Investments | $481.4M | +12.1% | +2.0% |
| Accounts Receivable | $74.2M | -49.5% | -15.4% |
| Inventory | $212.6M | +2.1% | +20.8% |
| Current Assets | $1.04B | +2.6% | +10.1% |
| Total Assets |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | $179.7M | — | — |
| Capital Expenditures | $40.4M | — | — |
| Investing Cash Flow | -$85.0M | — | — |
| Financing Cash Flow | -$72.1M | — | — |
| Free Cash Flow | $139.3M | — | — |
| -35.5% |
| -33.5% |
| Income Tax | $10.1M | -39.1% | -30.5% |
| Net Income | $44.0M | -34.5% | -34.2% |
| EPS (Basic) | $0.93 | -34.0% | -33.6% |
| EPS (Diluted) | $0.92 | -34.8% | -34.3% |
| $1.95B |
| +0.8% |
| +7.5% |
| Current Liabilities | $108.6M | -13.5% | -17.2% |
| Total Liabilities | $202.6M | -6.7% | -9.6% |
| Stockholders' Equity | $1.74B | +1.8% | +10.0% |